netFormulary Oxfordshire Clinical Commissioning Group NHS
Formulary  
 Search
 Formulary Chapter 5: Infections - Full Chapter
Chapter Links...
 Details...
05.03.03.01  Expand sub section  Chronic hepatitis B
Adefovir Dipivoxil (Hepsera®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

Use by Consultant Hepatologist for oral Hepatitis B treatment only.

Not routinely commissioned by NHSE as per NICE CG165, IFR approval required.

APCO July 2011.

 
Link  NICE CG165: Hepatitis B (chronic) - incorporates TA96
Link  NICE TA96: Hep B - adefovir dipivoxil and pegylated interferon alpha-2a
   
Entecavir (Baraclude®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

Use by Consultant Hepatologist for oral Hepatitis B treatment only.

Funded by specialised commissioning.

APCO September 2008.

 
Link  NICE CG165: Hepatitis B (incorporates TA153)
Link  NICE TA153: Hepatitis B (chronic) - etecavir
   
 ....
 Non Formulary Items
Telbivudine  (Sebivo®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not recommended for the treatment of chronic hepatitis B as per NICE TA154.

APCO September 2008.

 
Tenofovir Alafenamide  (Vemlidy®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

For treating chronic hepatitis B (NICE TA435 - terminated appraisal).

APCO May 2017. 

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Red: Medicines which should only be prescribed in secondary care by a specialist.  

Amber Continuation

Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.   

Amber Shared Care Protocol

Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).   

Green

Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.   

Brown

Brown: Medicines which should only be prescribed in restricted circumstances.  

Black

Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.  

OCCG Green

not used  

netFormulary